Greater femoral head size may improve function and enhance stability after primary total hip replacement (THR) ([@CIT0003], [@CIT0010], [@CIT0019]). Previous studies have shown a greater range of movement with increasing head size ([@CIT0001], [@CIT0027]). Use of a larger head size is an attractive option in younger patients who require stability at higher levels of function, and in older patients in order to reduce dislocation risk. However, greater surface area may also increase wear rates, irrespective of bearing materials ([@CIT0009], [@CIT0013], [@CIT0026], [@CIT0005], [@CIT0020]), and there have been reports of excessive taper load with large-diameter bearings ([@CIT0025], [@CIT0028]). Larger heads have been associated with the use of alternative bearings, in order to reduce wear and improve implant longevity. The National Joint Registry (NJR) in England and Wales has described an increase in the use of larger femoral head sizes (over 28 mm)---from 5% to 50% between 2005 and 2010 ([@CIT0014]). Over the same period, the use of ceramic-on-polyethylene (CoP) and ceramic-on-ceramic (CoC) bearings has increased.

Medium-term revision rates are higher with CoC bearings than with metal-on-polyethylene (MoP) bearings generally, across registry data, and specifically, when the most commonly used implant in England and Wales (Corail stem/Pinnacle cup; DePuy Ltd., Leeds, UK) was analyzed ([@CIT0033], [@CIT0022]). Larger femoral sizes using hard-bearing technology did not give any functional improvement over 28-mm MoP ([@CIT0017]) in a small randomized trial, and larger head sizes have not been found to offer any gait-related benefits ([@CIT0035]). The functional benefits of increasing head size and alternative bearings have yet to fully assessed.

Patient-reported outcome measures (PROMs) supplement revision risk in the assessment of success after joint replacement ([@CIT0012]). PROMs are routinely collected on National Health Service (NHS) patients undergoing THR in England. Data on hip replacement patients, their surgeons, and the implants used are collected by the NJR. These datasets can be linked in order to compare early outcomes for specific patient and implant groups at the national level. The present analysis explored the effect of bearing surface and femoral head size on PROMs and complications following THR. We hypothesized that larger heads and alternative bearings would have no functional benefit over standard (28-mm MoP) bearings.

Material and methods {#ss1}
====================

Design {#ss2}
------

We conducted a cohort study using prospectively collected patient-level NJR and PROMs-linked data to compare outcome scores and self-reported complications after primary THR for different head sizes and different bearings.

Data {#ss3}
----

The national PROMs study collects joint-specific and general health scores preoperatively and around 6 months postoperatively, and self-reported complications. By linking databases at the patient level, PROMs data can be combined with the corresponding demographic and operative details held in the NJR. To link them, a number of criteria were used: firstly, to ensure correct matching, 2 unique identifiers (NJR and procedure numbers) recorded in both datasets were used; secondly, the operation date recorded by the patient in the PROMs data had to be within ± 30 days of the operation date recorded on the NJR record, to ensure that the patient was scoring the same procedure.

We chose to perform the analysis using the single most commonly used brand of THR used in England and Wales (Corail stem/Pinnacle cup; DePuy Ltd., Leeds, UK), in order to control for any implant-related influences ([@CIT0014]).

There were a number of exclusion criteria. For the NJR data, these were: all procedures with an indication other than OA, procedures with missing implant or patient data, head sizes smaller than 28 mm and larger than 36 mm, and rarely used bearings (ceramic-on-metal and metal-on-ceramic). Metal-on-metal bearings were also excluded, as few of these are now implanted ([@CIT0014]). Procedures with PROMs data that were missing, undated, dated more than 12 months prior to or following the operation, or that had non-identical duplicates were excluded; for identical duplicates, the first record was retained for analysis. Where the presence of a co-morbidity or complication was asked for in the questionnaire but left blank by the patient, it was assumed to be absent. The study population is summarized in [Figure 1](#F1){ref-type="fig"}. The PROMs project was introduced in April 2008. Linkage of NJR data to PROMs was possible between this date and December 2010 (the limit of our access to NJR data). Details regarding the delivery and return of PROMs questionnaires were not available for this study. The demographic, surgical, and implant-related variables available for analysis are listed in [Table 1](#s1){ref-type="supplementary-material"} (see Supplementary data).

![Flow chart describing the study cohort. MoP -- metal-on-polyethylene, CoP -- ceramic-on-polyethylene, CoC --ceramic-on-ceramic. **^a^**Invalid PROMs data includes records with missing outcome score rccords, preoperative scores dated more than 12 months prior to operation, postoperative records without a date or dated \< 6 months or \> 12 months following the primary hip replacement, non-identical duplicates (all excluded) and identical duplicates (only one record retained).](ORT-86-032-g001){#F1}

The national PROMs project uses validated measures of hip-specific outcomes (Oxford hip score (OHS)) ([@CIT0011]) and general health outcomes (EuroQol (EQ-5D)) (EuroQol group 2009). For this analysis, the outcomes of interest were improvements between preoperative and postoperative scores (the "change scores") and self-reported postoperative complications (bleeding, wound problems, re-admission, and reoperation). Change scores, being approximately normally distributed, are analytically preferable to postoperative scores ([@CIT0006]). The OHS (score 0--48) has previously been shown to be a reliable, valid, and responsive outcome measure ([@CIT0029]). A threshold of 3 points has been proposed to demonstrate a clinically important difference ([@CIT0029]). The EQ-5D index (score --0.59 to 1.00) is a generic measure of health used for clinical and economic appraisal. It evaluates 5 different aspects of general health (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that are scored and combined using population weightings to produce a single index value for health status ([@CIT0015]). Patients are also asked about comorbidities, general health, and self-reported disability as part of the preoperative PROMs questionnaire. These can be used to adjust for differences in health status between patient groups. Sample sizes for all the head-size and bearing groups were in excess of the minimum numbers identified in the PROMs feasibility pilot for identification of meaningful differences (more than 150 per group) ([@CIT0006]).

Patients are also asked to indicate their satisfaction with the outcome following surgery (excellent, very good, good, fair, or poor), and whether they deem surgery to have been a success (much better, a little better, about the same, a little worse, or much worse). While unadjusted values have been provided for information, no attempt was made to adjust for baseline differences in either success or satisfaction, as previous analyses have demonstrated that the variables available within the NJR and PROMs databases are insufficient to explain these differences (i.e. the influence of unmeasured variables has a greater effect than the effect of the measured variables) ([@CIT0006], [@CIT0016]).

Statistics {#ss4}
----------

The variables available for the analyses are shown in [Table 1](#s1){ref-type="supplementary-material"} (see Supplementary data). The head sizes analyzed were 28 mm, 32 mm, and 36 mm. The bearings were MoP, CoP, and CoC. Differences in baseline characteristics across the groups would be a source of confounding in any comparative analysis. Thus, to test the hypothesis that there were no differences between groups, the following tests were employed: 1-way analysis of variance (ANOVA, parametric continuous data variables), the Kruskal-Wallis test (non-parametric continuous data variables), or the chi-square test (categorical data variables).

Univariable analysis was performed initially to identify variables that possibly influenced each outcome, based on statistical rejection criteria of p \> 0.1; these variables were then included in the multivariable models. Analysis of covariance (ANCOVA) was used for testing of differences in OHS and EQ5D index change scores across head size and bearing groups. Multivariable logistic regression was used to analyze differences in the risk of each of the complications across groups. Time from implantation to questionnaire completion was included in models to evaluate whether differences in duration of follow-up influenced findings. Preoperative scores were included in all models, as recommended by the designers of the Oxford hip score ([@CIT0029]).

Reflecting analysis of a large dataset, statistical models for the change scores were evaluated with the margins function in STATA in order to provide predicted values (including 99% confidence intervals (CIs)) separately for each of the head-size and bearing categories. p-values are provided as statistical evaluation of the differences between the reference (head size of 28 mm and MoP bearing) and other variables within the category. For complication risks, results are presented as odds ratios (ORs) with CIs: ratios greater than 1 indicate that risk is higher when compared with the reference category. Due to the statistical methods employed and the large population size, only covariates fitting models with p \< 0.01 were retained in final models as significant influences, to reduce the risk of type-1 error. All models were fitted using STATA 12.

For more information on the statistical techniques used, see Supplementary data.

Ethics {#ss5}
------

Explicit patient consent was taken for both the NJR and PROMs data collection. Further ethics approval is not required for registry studies in the UK.

Results {#ss6}
=======

There were 4,596 NJR-PROMs linked primary procedures. MoP accounted for 47% (2,171), CoC for 45% (2,064), and CoP for 7.9% (361). A standard (28-mm) head size was used in 41% of procedures (1,864), the 36-mm in 41% (1,863), and the 32-mm in 19% (869). When the demographics were compared across bearing groups, patients with a CoC bearing were generally younger and in better health, but there were comparable numbers of women in each group and mean BMI was similar. Patients who had a larger head size implanted were generally younger and in better health ([Table 2](#T2){ref-type="table"}). Patients fitted with a 32-mm head generally had a higher ASA grade and higher BMI, and poorer general health. Although there were statistically significant differences between categories of bearing and head size for each of the surgical covariates as a result of the large study population, the groups were qualitatively similar and therefore broadly comparable ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

###### 

Patient demographics for the population studied, by head size

                                                    All patients            28 mm (Reference)       Head size 32 mm           36 mm                   p-value [**^a^**](#T2-F1){ref-type="fn"}
  ------------------------------------------------- ----------------------- ----------------------- ------------------------- ----------------------- ------------------------------------------
  Number (%)                                        4,596                   1,864 (40.6)            869 (18.9)                1,863 (40.5)            
  *Patient factors*                                                                                                                                   
   Age, mean (SD) range                             66.0 (9.7) 25.2--95.1   68.0 (8.9) 31.0--95.1   68.2 (10.1) 26.2-- 94.1   62.9 (9.5) 25.2--90.2   \< 0.001
   Females, n (%)                                   2,620 (57.0)            1,303 (69.9)            535 (61.6)                782 (42.0)              \< 0.001
   ASA, n (%)                                                                                                                 \< 0.001                
    1                                               804 (17.5)              286 (15.3)              93 (10.7)                 425 (22.8)              
    2                                               3,360 (73.1)            1,410 (75.6)            644 (74.1)                1,306 (70.1)            
    3+                                              432 (9.4)               168 (9.0)               132 (15.2)                132 (7.1)               
   BMI (SD) range[**^b^**](#T2-F2){ref-type="fn"}   29.0 (5.4) 15--65       28.7 (5.2) 15--56       29.1 (5.6) 16--50         29.5 (5.4) 16--65       0.03
   Comorbidities, n (%)                                                                                                                               
    Heart disease                                   388 (8.4)               152 (8.2)               91 (10.5)                 145 (7.8)               0.05
    Stroke                                          67 (1.5)                29 (1.6)                13 (1.5)                  25 (1.3)                0.9
    Diabetes                                        355 (7.7)               158 (8.5)               70 (8.1)                  127 (6.8)               0.2
    Hypertension                                    1,764 (38.4)            739 (39.7)              366 (42.1)                659 (35.4)              0.001
    Circulation                                     221 (4.8)               102 (5.5)               45 (5.2)                  74 (4.0)                0.09
    Lung                                            270 (5.9)               112 (6.0)               42 (4.8)                  116 (6.2)               0.3
    Depression                                      309 (6.7)               126 (6.8)               44 (5.1)                  139 (6.7)               0.07
   Preoperative general health                                                                                                                        0.02
    Excellent                                       265 (5.8)               100 (5.4)               53 (6.1)                  114 (6.1)               
    Very good                                       1,413 (30.7)            566 (30.4)              235 (27.0)                611 (32.8)              
    Good                                            2,008 (43.7)            862 (46.2)              394 (45.3)                755 (40.5)              
    Fair                                            781 (17.0)              285 (15.3)              165 (19.0)                330 (17.7)              
    Poor                                            129 (2.9)               51 (2.7)                22 (2.5)                  53 (2.8)                
   Preoperative disability                          2,229 (48.5)            928 (50.0)              448 (51.6)                853 (45.8)              0.007
  *Surgical factors*                                                                                                                                  
   Chemical VTE prophylaxis                                                                                                   \< 0.001                
    LMWH only                                       2,583 (56.2)            1,115 (59.8)            518 (59.6)                950 (51.0)              
    Aspirin only                                    415 (9.0)               146 (7.8)               50 (5.8)                  219 (11.8)              
    Other                                           544 (11.8)              163 (8.7)               98 (11.3)                 283 (15.2)              
    None                                            304 (6.6)               133 (7.1)               36 (4.1)                  135 (7.3)               
    Not recorded                                    750 (16.3)              307 (16.5)              167 (19.2)                276 (14.8)              
   Mechanical VTE prophylaxis                                                                                                 \< 0.001                
    Compression stockings (CS)                      1,249 (27.2)            500 (26.8)              222 (25.6)                527 (28.3)              
    CS + mechanical pump                            918 (20.0)              296 (15.9)              134 (15.4)                488 (26.2)              
    Foot pump only                                  523 (11.4)              278 (14.9)              86 (9.9)                  159 (8.5)               
    Mechanical calf pump only                       756 (16.5)              312 (16.7)              173 (19.9)                271 (14.6)              
    Other                                           22 (0.5)                7 (0.4)                 0 (0.0)                   15 (1.0)                
    None                                            378 (8.2)               164 (8.8)               87 (6.8)                  127 (6.8)               
    Not recorded                                    750 (16.3)              307 (16.5)              167 (19.2)                276 (14.8)              
   Bearing                                                                                                                    \< 0.001                
    Metal-on-polyethylene                           2,171 (47.2)            1,423 (76.3)            510 (58.7)                238 (12.8)              
    Ceramic-on-polyethylene                         361 (7.9)               198 (10.6)              100 (11.5)                63 (3.4)                
    Ceramic-on-ceramic                              2,064 (44.9)            243 (13.0)              259 (29.8)                1,562 (83.8)            
   Anesthesia                                                                                                                 \< 0.001                
    Regional                                        2,077 (45.2)            871 (46.7)              303 (34.9)                903 (48.5)              
    General                                         827 (18.0)              312 (16.7)              168 (19.3)                347 (18.6)              
    Regional and general                            906 (19.7)              357 (19.2)              224 (25.8)                325 (17.4)              
    Not recorded                                    786 (17.1)              324 (17.4)              174 (20.0)                288 (15.5)              
   Lead surgeon grade                                                                                                                                 \< 0.001
    Consultant                                      3,475 (75.6)            1,484 (79.6)            618 (71.1)                1,373 (73.7)            
    Other                                           1,121 (24.4)            380 (20.4)              251 (28.9)                490 (26.3)              
   Position                                                                                                                   0.02                    
    Lateral                                         3,598 (78.3)            1,449 (77.7)            666 (76.6)                1,483 (79.6)            
    Supine                                          248 (5.4)               108 (5.8)               36 (4.1)                  104 (5.6)               
    Not recorded                                    750 (16.3)              307 (16.5)              167 (19.2)                276 (14.8)              

ASA: American Society of Anaesthesiologists score; PROMs: patient-reported outcomes measures.

Difference between groups with 1-way ANOVA (continuous data variables) or chi-squared test (categorical data variables).

BMI (body mass index) data on 2,726.

###### 

Patient demographics for the population studied, by bearing

                                                    All patients            Metal-on-polyethylene (Reference)   Bearing Ceramic-on-polyethylene   Ceramic-on-ceramic      p-value [**^a^**](#T3-F1){ref-type="fn"}
  ------------------------------------------------- ----------------------- ----------------------------------- --------------------------------- ----------------------- ------------------------------------------
  Number (%)                                        4,596                   2,171 (47.2)                        361 (7.9)                         2,064 (44.9)            
  *Patient factors*                                                                                                                                                       
   Age, mean (SD) range                             66.0 (9.7) 25.2--95.1   70.8 (8.0) 31.0--95.1               64.6 (8.3) 39.0--87.2             61.1 (9.1) 25.2--91.5   \< 0.001
   Females, n (%)                                   2,620 (57.0)            1,259 (58.0)                        220 (60.9)                        1,141 (55.3)            0.06
   ASA, n (%)                                                                                                                                                             \< 0.001
    1                                               804 (17.5)              246 (11.3)                          64 (17.7)                         494 (23.9)              
    2                                               3,360 (73.1)            1,673 (77.1)                        249 (69.0)                        1,438 (69.7)            
    3+                                              432 (9.4)               252 (11.6)                          48 (13.3)                         132 (6.4)               
   BMI (SD) range[**^b^**](#T3-F2){ref-type="fn"}   29.0 (5.4) 15--65       28.7 (5.2) 15--56                   29.3 (5.3) 18--54                 29.2 (5.6) 18--65       0.09
   Comorbidities, n (%)                                                                                                                                                   
    Heart disease                                   388 (8.4)               233 (10.7)                          28 (7.8)                          127 (6.2)               \< 0.001
    Stroke                                          67 (1.5)                42 (1.9)                            4 (1.1)                           21 (1.0)                0.04
    Diabetes                                        355 (7.7)               201 (9.3)                           27 (7.5)                          127 (6.2)               0.001
    Hypertension                                    1,764 (38.4)            960 (44.2)                          136 (37.7)                        668 (32.4)              \< 0.001
    Circulation                                     221 (4.8)               132 (6.1)                           25 (6.9)                          64 (3.1)                \< 0.001
    Lung                                            270 (5.9)               122 (5.6)                           21 (5.8)                          127 (6.2)               0.8
    Depression                                      309 (6.7)               123 (5.7)                           25 (6.9)                          161 (7.8)               0.02
   Preoperative general health                                                                                                                    0.001                   
    Excellent                                       265 (5.8)               104 (4.8)                           20 (5.5)                          137 (6.6)               
    Very good                                       1,413 (30.7)            649 (29.9)                          93 (25.8)                         669 (32.4)              
    Good                                            2,008 (43.7)            1,004 (46.2)                        184 (51.0)                        819 (39.7)              
    Fair                                            781 (17.0)              363 (16.7)                          53 (14.7)                         380 (18.4)              
    Poor                                            129 (2.9)               51 (2.3)                            11 (3.0)                          59 (2.9)                
   Preoperative disability                          2,229 (48.5)            1,117 (51.5)                        192 (53.2)                        920 (44.6)              \< 0.001
  *Surgical factors*                                                                                                                                                      
   Chemical VTE prophylaxis                                                                                                                                               \< 0.001
    LMWH only                                       2,583 (56.2)            1,322 (60.9)                        211 (49.0)                        1,050 (50.9)            
    Aspirin only                                    415 (9.0)               179 (8.3)                           21 (5.8)                          215 (10.4)              
    Other                                           544 (11.8)              189 (8.7)                           45 (12.5)                         310 (15.0)              
    None                                            304 (6.6)               115 (5.3)                           27 (7.5)                          62 (7.8)                
    Not recorded                                    750 (16.3)              366 (16.9)                          57 (15.8)                         327 (15.8)              
   Mechanical VTE prophylaxis                                                                                                                                             \< 0.001
    Compression stockings (CS)                      1,249 (27.2)            644 (29.7)                          98 (27.2)                         507 (24.6)              
    CS + mechanical pump                            918 (20.0)              342 (15.8)                          79 (21.9)                         497 (24.1)              
    Foot pump only                                  523 (11.4)              324 (14.9)                          10 (2.8)                          189 (9.2)               
    Mechanical calf pump only                       756 (16.5)              311 (14.3)                          70 (19.4)                         375 (18.2)              
    Other                                           22 (0.5)                4 (0.2)                             1 (0.3)                           17 (0.8)                
    None                                            378 (8.2)               180 (8.3)                           46 (12.7)                         152 (7.4)               
    Not recorded                                    750 (16.3)              366 (16.9)                          57 (15.8)                         327 (15.4)              
   Head size                                                                                                                                                              \< 0.001
    28 mm                                           1,864 (40.6)            1,423 (65.6)                        198 (54.9)                        243 (11.8)              
    32 mm                                           869 (18.9)              510 (23.5)                          100 (27.7)                        869 (18.9)              
    36 mm                                           1,863 (40.5)            238 (11.0)                          63 (17.5)                         1,562 (40.5)            
   Anesthesia                                                                                                                                                             0.01
    Regional                                        2,077 (45.2)            987 (45.5)                          153 (42.4)                        937 (45.4)              
    General                                         827 (18.0)              344 (15.9)                          72 (19.9)                         411 (19.9)              
    Regional and general                            906 (19.7)              454 (20.9)                          77 (18.2)                         375 (18.2)              
    Not recorded                                    786 (17.1)              386 (17.8)                          59 (16.3)                         341 (16.5)              
   Lead surgeon grade                                                                                                                                                     0.002
    Consultant                                      3,475 (75.6)            1,600 (73.7)                        294 (81.4)                        1,581 (76.6)            
    Other                                           1,121 (24.4)            571 (26.3)                          67 (18.6)                         483 (23.4)              
   Position                                                                                                                                                               0.1
    Lateral                                         3,598 (78.3)            1,708 (78.7)                        284 (78.7)                        1,606 (77.8)            
    Supine                                          248 (5.4)               97 (4.5)                            20 (5.5)                          131 (6.4)               
    Not recorded                                    750 (16.3)              366 (16.9)                          57 (15.8)                         327 (15.8)              

ASA: American Society of Anaesthesiologists score; PROMs: patient-reported outcomes measures.

Difference between groups with 1-way ANOVA (continuous data variables) or chi-squared test (categorical data variables).

BMI (body mass index) data on 2,726.

In the unadjusted PROMs data, patients with a CoC bearing and a larger head size generally had higher preoperative and postoperative OHS and EQ5D indices. Patient-reported levels of satisfaction and success were similar across the bearing groups and the 28-mm and 36-mm head size groups, although the 32-mm head size group had poorer scores ([Tables 4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}).

###### 

Patient-reported outcomes for populations studied, by bearing

                                                                  Metal-on-polyethylene      Ceramic-on-polyethylene         Ceramic-on-ceramic    p-value [**^a^**](#T4-F1){ref-type="fn"}
  --------------------------------------------------------------- -------------------------- ------------------------------- --------------------- ------------------------------------------
  Number (%)                                                      2,171 (47.2)               361 (7.9)                       2,064 (44.9)          
  Oxford hip score                                                                                                                                 
   Preoperative, mean (SD) range                                  18.4 (8.0) 1--43           18.5 (8.4) 0--43                19.2 (8.1) 1--46      0.003
   Postoperative, median (range)                                  42 (0--48)                 41 (7--48)                      43 (2--48)            \< 0.001
  EQ5D index                                                                                                                                       
   Preoperative, mean (SD) range                                  0.368 (0.314)-0.349 to 1   0.375 (0.331) -0.484 to 0.883   0.394 (0.311)         0.01 -0.594 to 1
   Postoperative, median (range)                                  0.815 (-0.319 to 1)        0.796 (-0.319 to 1)             0.848 (-0.594 to 1)   0.008
  Satisfaction, n (%)                                                                                                                              0.3
   Excellent                                                      882 (40.6)                 144 (39.9)                      887 (43.0)            
   Very good                                                      804 (37.0)                 123 (34.1)                      728 (35.3)            
   Good                                                           364 (16.8)                 66 (18.3)                       321 (15.6)            
   Fair                                                           90 (4.2)                   23 (6.4)                        89 (4.3)              
   Poor                                                           31 (1.4)                   5 (1.4)                         39 (1.9)              
  Success, n (%)                                                                                                                                   0.05
   Much better                                                    1,936 (89.2)               303 (83.9)                      1,828 (88.6)          
   A little better                                                157 (7.2)                  46 (12.7)                       158 (7.7)             
   About the same                                                 33 (1.5)                   3 (0.8)                         35 (1.7)              
   A little worse                                                 26 (1.2)                   6 (1.7)                         29 (1.4)              
   Much worse                                                     19 (0.9)                   3 (0.8)                         14 (0.7)              
  Time from operation to PROMs completion, mean days (SD) range   208 (28) 183--363          207 (23) 183--333               210 (29) 183--361     0.002

PROMs: patient-reported outcome measures.

1-way ANOVA was used for parametric data, Kruskal-Wallis test for non-parametric data, and chi-squared test for proportions.

###### 

Patient-reported outcomes for populations studied, by head size

                                                                  28 mm                       32 mm                       36 mm                       p-value [**^a^**](#T5-F1){ref-type="fn"}
  --------------------------------------------------------------- --------------------------- --------------------------- --------------------------- ------------------------------------------
  Number (%)                                                      1,864 (40.6)                869 (18.9)                  1,863 (40.5)                
  Oxford hip score                                                                                                                                    
   Preoperative, mean (SD) range                                  18.2 (8.0) 1--44            18.3 (7.9) 2--43            19.6 (8.2) 0--46            \< 0.001
   Postoperative, median (range)                                  43 (0--48)                  41 (4--48)                  48 (2--48)                  \< 0.001
  EQ5D index                                                                                                                                          
   Preoperative, mean (SD) range                                  0.366 (0.315) -0.484 to 1   0.365 (0.316) -0.319 to 1   0.401 (0.311) -0.594 to 1   0.001
   Postoperative, median (range)                                  0.848 (-0.319 to 1)         0.796 (-0.126 to 1)         0.850 (-0.594 to 1)         \< 0.001
  Satisfaction, n (%)                                                                                                                                 \< 0.001
   Excellent                                                      791 (42.4)                  319 (36.7)                  803 (43.1)                  
   Very good                                                      683 (36.6)                  299 (34.4)                  673 (36.1)                  
   Good                                                           288 (15.5)                  190 (21.9)                  273 (14.7)                  
   Fair                                                           77 (4.1)                    46 (5.3)                    79 (4.2)                    
   Poor                                                           25 (1.3)                    15 (1.7)                    35 (1.9)                    
  Success, n (%)                                                                                                                                      0.001
   Much better                                                    1,673 (89.8)                736 (84.7)                  1,658 (89.0)                
   A little better                                                124 (6.7)                   103 (11.9)                  134 (7.2)                   
   About the same                                                 27 (1.5)                    14 (1.6)                    30 (1.6)                    
   A little worse                                                 22 (1.2)                    10 (1.2)                    29 (1.6)                    
   Much worse                                                     18 (1.0)                    6 (0.7)                     12 (0.6)                    
  Time from operation to PROMs completion, mean days (SD) range   207 (26) 183--361           209 (28) 184--357           210 (29) 183--363           0.002

PROMs: patient-reported outcome measures.

1-way ANOVA was used for parametric data, Kruskal-Wallis test for non-parametric data, and chi-squared test for proportions.

Improvement in outcome score {#ss7}
----------------------------

Improvements in OHS and EQ5D index were similar for MoP, CoP, and CoC bearings ([Table 6](#s1){ref-type="supplementary-material"}, see Supplementary data).

Improvements in OHS and EQ5D index were similar for a 28-mm and a 36-mm head. Although the difference was small, the 32-mm head was associated with a poorer outcome (OHS: 20, 99% CI: 19--21, p = 0.002; EQ5D index: 0.39, 99% CI: 0.36--0.42, p = 0.004) ([Table 7](#s1){ref-type="supplementary-material"}, see Supplementary data).

Risk of complications {#ss8}
---------------------

There were no statistically significant differences in risk of bleeding, wound complications, re-admission, or reoperation after case-mix adjustment when the bearing groups were compared ([Table 8](#s1){ref-type="supplementary-material"}, see Supplementary data). Bleeding risk was higher in the 32-mm head-size group (OR = 1.8, 99% CI: 1.2--2.8, p \< 0.001) but not in the 36-mm head-size group (OR 1.3, CI 0.9 to 2.0, 0.063) when compared with the 28-mm group. Risk of wound complications was higher in the 36-mm group (OR = 1.7, 99% CI: 1.1--2.6, p = 0.002). Re-admission and reoperation risks were similar when the different head sizes were compared ([Table 9](#s1){ref-type="supplementary-material"}, see Supplementary data).

Discussion {#ss9}
==========

This large cohort study using NJR-PROMs linked data from a single hip system showed no functional benefit when femoral head sizes greater than 28 mm and bearings other than MoP were used for primary THR. These findings are important for clinicians attempting to determine the most suitable hip implants for patients with osteoarthritis.

While this is the largest study to date to report the effects of head size and bearing type on functional outcome for a single hip replacement brand, there are some potential limitations to our findings. The study design was observational and thus vulnerable to omitted variables, which may have confounded the findings. Some data were unavailable for analysis; for example, radiological data on cup positioning. There were also large numbers of procedures that could not be analyzed, either because the datasets could not be linked (for example, due to missing patient identification details) or because there were specific data fields with incomplete data. Moreover, any bias in completion and return of PROMs cannot be assessed, as no details were available regarding the number of questionnaires sent out or returned. Non-responders are more likely to be younger patients (and therefore more likely to have larger head sizes and alternative bearings). However, previous PROMs analyses have demonstrated that non-responders generally perform more poorly ([@CIT0031]). Irrespective of these issues, similarities between the unadjusted and adjusted models and robustness under different model fitting assumptions support the stability of estimates.

By restricting the implants to the most commonly used brand only, we were able to remove the problems associated with adjusting for multiple brands (differing implant design characteristics and bearing surface manufacturing processes). The Corail Pinnacle constitutes 14% of all hip implants used in England and Wales since 2003. Cementless components now predominate, and around 40% of those implanted in 2011 were Corail Pinnacle (England-and-Wales-National-Joint-Registry 2012). \[Ann-Britt: v.v. ta bort bindestrecken\] This implant combination also offers a wide range of bearing options and head sizes, making it a good choice for analysis, and sample sizes of each of the comparison groups were in excess of the minimum numbers required to identify meaningful differences ([@CIT0006]). False-negative results are therefore unlikely, especially as OHS and EQ5D indices for each of the groups were qualitatively similar, irrespective of confidence intervals.

As with all NJR-PROMs studies, the design of the study was constrained by the data available. In particular, this limited the length of follow-up available and the measures of hip function used. Although functional outcome at 6 months can be described as early, the follow-up in this study was adequate for group comparisons. The literature shows little improvement in change in OHS between 6 months and 5 years following hip replacement, suggesting that the results in our short-term study are a reliable indication of longer-term outcome ([@CIT0002], [@CIT0023]).

Greater femoral head size may reduce dislocation risk. In a randomized trial of patients undergoing metal-on-highly-crosslinked polyethylene hip replacements, [@CIT0018] found that a head size of 36 mm reduced the 1-year dislocation risk compared to 28 mm in 533 primary procedures---from 4.4% to 0.8%. In addition, a large cohort study of over 240,000 THRs performed in England and Wales found a reduction in 1-year dislocation risk from 1.4% to 1.1% over a period of 5 years, during which the use of large femoral head sizes increased. However, there was no change in the 12-month revision rate ([@CIT0021]). Lower dislocation rates with larger femoral head sizes have also been found in Australian and Norwegian registry data ([@CIT0008], [@CIT0030]). Without radiographic data, dislocation risk is difficult to analyze. The 1-year risk in the study by [@CIT0018] is high compared to others; [@CIT0034] reported dislocation with head sizes less than 36 mm of only 1.8% (10 in 559) at 5 years, which is similar to the English NHS data (taking into account that most dislocations occur in the first year after surgery) ([@CIT0021]). Before larger head sizes are recommended, the incidence of late dislocation, wear, periprosthetic osteolysis, and liner fracture should also be established ([@CIT0018]). Importantly, revision risk did not decrease in the English NHS data, suggesting that most early dislocations are relatively benign and do not require a revision procedure. Although dislocation data were unavailable in the current study, other outcomes were used as surrogate endpoints. The majority of dislocations following primary THR occur within the first 5 weeks after surgery ([@CIT0004]); therefore, patient-reported complications associated with a dislocation, such as re-admission and reoperation, should demonstrate a difference if, for example, one head size had a lower risk than another. Increasing femoral head size may also increase range of movement, but several studies have shown that it is the patient's bony anatomy that causes impingement, and therefore limits this range irrespective of head size ([@CIT0007], [@CIT0024]). Interestingly, PROMs were poorer and bleeding risk was higher in patients implanted with a 32-mm head. This may be explained by the patient demographics, which showed a slightly greater mean BMI and relatively more patients with higher ASA grade and poorer health. In these patients, a surgeon may choose to increase head size from 28 mm in an attempt to increase stability, thereby potentially reducing a need for further revision surgery. Differences in unmeasured patient variables across groups (which cannot be controlled) may also account for this finding. However, it must be stressed that the statistically significant OHS change difference of 1.4 between 28-mm and 32-mm femoral heads is unlikely to be clinically significant.

Medium- to long-term risk of revision is lowest in MoP bearings across worldwide registries and published trials, and no functional benefit of alternative bearings has so far been found ([@CIT0032]). When implant survival of 35,386 Corail Pinnacle THRs was examined in the NJR cohort, hard bearings had a higher revision risk than MoP (MoM: HR = 1.9, p \< 0.001; CoC: HR = 1.6, p = 0.003) ([@CIT0022]). In a randomized trial of 49 patients who received either large-head MoM articulations or standard (28- to 32-mm) MoP THRs, no statistically significant benefits were found in function, dislocation, or implant failure ([@CIT0017]), although the numbers are small and this could be a consequence of type-II statistical error.

Metal-on-metal bearings were not included in this study. Although a large number of Corail Pinnacle THRs have been implanted in England and Wales with these bearings, their use is now low due to high revision rates and concerns regarding the systemic effects of excessive metal wear debris.

In summary, no functional benefits of larger head sizes or alternative bearings were found in this national analysis of NJR-PROMs linked THRs, after adjusting for other influences. Given the lack of evidence in the literature of improved implant survival with these implant options, we question their use in routine primary THR.

Supplementary data {#ss10}
------------------

[Tables 1 and 6--9](#s1){ref-type="supplementary-material"} are available at Acta's website ([www.actaorthop.org](www.actaorthop.org)), identification number 7059.
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